These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3660401)

  • 1. Characteristics of anti-TSH receptor antibodies in two patients who developed spontaneous hypothyroidism after antithyroid drug therapy for hyperthyroid Graves' disease.
    Kaise K; Kaise N; Yoshida K; Itagaki Y; Yamamoto M; Sakurada T; Saito S; Yoshinaga K
    Tohoku J Exp Med; 1987 Jul; 152(3):269-75. PubMed ID: 3660401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on monoclonal antibodies to TSH receptors--heterogeneity and pathophysiological significance of antibodies to TSH receptor].
    Yoshida T
    Nihon Naibunpi Gakkai Zasshi; 1986 Dec; 62(12):1384-99. PubMed ID: 3817231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
    Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
    Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyrotropin receptor antibodies in hypothyroid Graves' disease.
    Kasagi K; Hidaka A; Nakamura H; Takeuchi R; Misaki T; Iida Y; Konishi J
    J Clin Endocrinol Metab; 1993 Feb; 76(2):504-8. PubMed ID: 8094394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two Graves' disease patients who spontaneously developed hypothyroidism after antithyroid drug treatment: characteristics of epitopes for thyrotropin receptor antibodies.
    Chung HK; Kim WB; Park DJ; Kohn LD; Tahara K; Cho BY
    Thyroid; 1999 Apr; 9(4):393-9. PubMed ID: 10319947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mechanism of spontaneous hypothyroidism in patients with Graves' disease after antithyroid drug treatment.
    Tamai H; Hirota Y; Kasagi K; Matsubayashi S; Kuma K; Iida Y; Konishi J; Okimura MC; Walter RM; Kumagai LF
    J Clin Endocrinol Metab; 1987 Apr; 64(4):718-22. PubMed ID: 2434520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible primary hypothyroidism with blocking or stimulating type TSH binding inhibitor immunoglobulin following recombinant interferon-alpha therapy in patients with pre-existing thyroid disorders.
    Chen FQ; Okamura K; Sato K; Kuroda T; Mizokami T; Fujikawa M; Tsuji H; Okamura S; Fujishima M
    Clin Endocrinol (Oxf); 1996 Aug; 45(2):207-14. PubMed ID: 8881454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-TSH antibodies in Graves' disease and their failure to interact with TSH receptor antibodies.
    Ochi Y; Nagamune T; Nakajima Y; Ishida M; Kajita Y; Hachiya T; Ogura H
    Acta Endocrinol (Copenh); 1989 Jun; 120(6):773-7. PubMed ID: 2567103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperthyroidism following hypothyroidism.
    McDermott MT; Kidd GS; Dodson LE; Hofeldt FD
    Am J Med Sci; 1986 Mar; 291(3):194-8. PubMed ID: 3006488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperthyroid Graves' disease and primary hypothyroidism caused by TSH receptor antibodies in monozygotic twins: case reports.
    Tani J; Yoshida K; Fukazawa H; Kiso Y; Sayama N; Mori K; Aizawa Y; Hori H; Nakasato N; Abe K
    Endocr J; 1998 Feb; 45(1):117-21. PubMed ID: 9625455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on the thyrotropin receptor and adenylate cyclase activity in various thyroid diseases: I. The properties of TSH receptor and adenylate cyclase in Graves' thyroid and retro-orbital adipose tissues (author's transl)].
    Abe Y
    Nihon Naibunpi Gakkai Zasshi; 1980 May; 56(5):739-53. PubMed ID: 6248386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to the thyrotropin receptor.
    Rees Smith B; McLachlan SM; Furmaniak J
    Endocr Rev; 1988 Feb; 9(1):106-21. PubMed ID: 3286231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
    Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
    Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of spontaneous hypothyroidism in patients with Graves' disease treated with antithyroidal drugs: clinical, immunological, and histological findings in 26 patients.
    Tamai H; Kasagi K; Takaichi Y; Takamatsu J; Komaki G; Matsubayashi S; Konishi J; Kuma K; Kumagai LF; Nagataki S
    J Clin Endocrinol Metab; 1989 Jul; 69(1):49-53. PubMed ID: 2471711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence against the importance in the disease process of antibodies to bovine thyroid-stimulating hormone found in some patients with Graves' disease.
    Noh J; Hamada N; Saito H; Oyanagi H; Ishikawa N; Momotani N; Ito K; Morii H
    J Clin Endocrinol Metab; 1989 Jan; 68(1):107-13. PubMed ID: 2909548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking type antithyrotropin receptor antibody in patients with nongoitrous hypothyroidism: its incidence and characteristics of action.
    Arikawa K; Ichikawa Y; Yoshida T; Shinozawa T; Homma M; Momotani N; Ito K
    J Clin Endocrinol Metab; 1985 May; 60(5):953-9. PubMed ID: 2858492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
    Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
    J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of thyrotropin-stimulated adenylate cyclase activation and growth of rat thyroid cells, FRTL-5, by immunoglobulin G from patients with primary myxedema: comparison with activities of thyrotropin-binding inhibitor immunoglobulins.
    Cho BY; Shong YK; Lee HK; Koh CS; Min HK
    Acta Endocrinol (Copenh); 1989 Jan; 120(1):99-106. PubMed ID: 2563181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotropin receptor non-mediated thyroid stimulating immunoglobulin in Graves' disease.
    Endo T; Haraguchi K; Ohmori M; Ikeda M; Ohta K; Onaya T
    Biochem Biophys Res Commun; 1991 Sep; 179(3):1543-7. PubMed ID: 1656957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.